Phase 3 ASCERTAIN Trial in MDS

Phase 3 ASCERTAIN Trial in MDS

User Photo
obr

6 months
36 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
James McCloskey, MD, Interim Chief, Division of Leukemia, John Theurer Cancer Center, Part of Hackensack University Medical Center, shares his impression of the Phase 3 ASCERTAIN study investigating cedazuridine and decitabine versus decitabine in myelodysplastic syndromes (MDS).
Up Next Autoplay
User Photo